You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bevacizumab failure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Adebrelimab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Jul 27, 2023

Metastatic Liver Cancer Trial in Shanghai (HAIC?Bevacizumab?Camrelizumab)

Not yet recruiting
  • Metastatic Liver Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 7, 2022

Recurrent Nasopharyngeal Carcinoma, Metastatic Nasopharyngeal Carcinoma, Chemo Effect Trial in Guangzhou (PD-1 Immune Checkpoint

Active, not recruiting
  • Recurrent Nasopharyngeal Carcinoma
  • +2 more
  • PD-1 Immune Checkpoint Inhibitor Combined With Bevacizumab
  • Guangzhou, Guangdong, China
    Yanqun Xiang
Sep 5, 2022

NSCLC Stage IIIB~IV Trial in Taipei (Atezolizumab Injection; bevacizumab Injection)

Recruiting
  • NSCLC Stage IIIB~IV
  • Atezolizumab Injection; bevacizumab Injection
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 18, 2022

Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer Trial (SHR-1701 + Pemetrexed Disodium + cisplatin/carboplatin +

Not yet recruiting
  • Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer
  • SHR-1701 + Pemetrexed Disodium + cisplatin/carboplatin + bevacizumab
  • +2 more
  • (no location specified)
Nov 12, 2021

Decision-making of ctDNA in mCRC After Failure of First-line

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab Ab; Bevacizumab; Vermofenib + cetuximab;Trastuzumab+lapatinib or trastuzumab+pertuzumab; others
  • (no location specified)
Apr 2, 2021

Neuroendocrine Carcinomas Trial in France (Folfiri-bevacizumab, Folfiri)

Recruiting
  • Neuroendocrine Carcinomas
  • Amiens, France
  • +26 more
Jan 26, 2022

Glioblastoma Trial in Boston, San Antonio (Bevacizumab, TH-302)

Completed
Has Results
  • Glioblastoma
  • Boston, Massachusetts
  • +1 more
Apr 9, 2020

End Stage Renal Disease, Hemodialysis Vascular Access Failure Trial (1.25mg bevacizumab, 2.50mg bevacizumab)

Withdrawn
  • End Stage Renal Disease
  • Hemodialysis Vascular Access Failure
  • 1.25mg bevacizumab
  • 2.50mg bevacizumab
  • (no location specified)
Jul 6, 2020

NSCLC Trial in United States (bevacizumab, erlotinib HCl, )

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Vallejo, California
  • +3 more
Dec 18, 2020

Lung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRT Trial in Shanghai (pemetrexed,cisplatin/carboplatin,bevacizumab,durvalumab,SBRT)

Not yet recruiting
  • Lung Cancer Stage IV，EGFR-mutant，TKI，PD-L1，SBRT
  • Shanghai, Shanghai, China
    Fudan University shanghai cancer center
Aug 16, 2020

Corneal Neovascularization, Corneal Graft Failure Trial in Miami, Boston, New York (Avastin® (bevacizumab), 0.9% NaCl & Refresh

Completed
Has Results
  • Corneal Neovascularization
  • Corneal Graft Failure
  • Avastin® (bevacizumab)
  • 0.9% NaCl & Refresh Liquigel
  • Miami, Florida
  • +2 more
Aug 6, 2020

EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Trial in Worldwide (Atezolizumab, Bevacizumab, Carboplatin)

Active, not recruiting
  • EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
  • Großhansdorf, Germany
  • +17 more
Jan 12, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Bevacizumab combined with Sintilimab, Transcatheter arterial chemoembolization)

Recruiting
  • Hepatocellular Carcinoma
  • Bevacizumab combined with Sintilimab
  • Transcatheter arterial chemoembolization
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Oct 14, 2023

Hepatocellular Carcinoma Trial in Munich, Würzburg (durvalumab, tremelimumab, bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • durvalumab, tremelimumab, bevacizumab
  • Munich, Germany
  • +2 more
May 3, 2023

Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)

Completed
  • Metastatic Breast Cancer
  • Chuo-ku, Nihonbashi, Koami-cho, Tokyo, Japan
    Japan Breast Cancer Research Group
Aug 2, 2022

Colorectal Cancer Trial in Hangzhou (RC48-ADC plus Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • RC48-ADC plus Bevacizumab
  • Hangzhou, Zhejinag, China
    The second affiliated hospital of Zhejiang University
Mar 24, 2023

NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Brain Neoplasms
  • (no location specified)
Dec 9, 2022

The ImmunoXXL Study

Recruiting
  • Hepatocellular Carcinoma
  • Liver Transplantation
  • Milano, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 25, 2023

Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

Recruiting
  • Unresectable Colon Cancer Peritoneal Metastases
  • PMMR/Ras/BRAF Wild-type
  • Serplulimab Combined With FOLFIRI and Bevacizumab
  • Huzhou, Zhejiang, China
    Changxing County People's Hospital
Feb 14, 2023

Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States

Active, not recruiting
Has Results
  • Invasive Breast Carcinoma
  • +3 more
  • Bevacizumab
  • +4 more
  • Mobile, Alabama
  • +525 more
Jan 28, 2023

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (bevacizumab, radiation therapy)

Completed
Has Results
  • Adult Giant Cell Glioblastoma
  • +3 more
  • bevacizumab
  • radiation therapy
  • Birmingham, Alabama
  • +30 more
Dec 27, 2022

Atezolizumab Plus Bevacizumab in Advanced HCC

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Atezolizumab plus bevacizumab
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Cha Medical Center
Oct 30, 2022

Hepatocellular Carcinoma, Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Trial in Dallas (Atezolizumab and

Not yet recruiting
  • Hepatocellular Carcinoma
  • Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
  • Atezolizumab and bevacizumab
  • transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Sep 9, 2022

Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States

Active, not recruiting
Has Results
  • Brain Stem Glioma
  • +4 more
  • Bevacizumab
  • +2 more
  • Birmingham, Alabama
  • +136 more
Oct 15, 2022